Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRA1 | P14867 | 3/20 | 0.48 |
| ▸ | GABRG2 | P18507 | 2/20 | 0.48 |
| ▸ | GABRB3 | P28472 | 2/20 | 0.48 |
| ▸ | GABRB2 | P47870 | 2/20 | 0.48 |
| ▸ | LMNA | P02545 | 2/20 | 0.48 |
| ▸ | FAAH | O00519 | 2/20 | 0.48 |
| ▸ | CA1 | P00915 | 1/20 | 0.48 |
| ▸ | CA2 | P00918 | 1/20 | 0.48 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.48 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.48 |
| ▸ | HPGD | P15428 | 1/20 | 0.48 |
| ▸ | TSHR | P16473 | 1/20 | 0.48 |
| ▸ | GABRB1 | P18505 | 1/20 | 0.48 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.48 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.48 |
| ▸ | HTR2C | P28335 | 1/20 | 0.48 |
| ▸ | GABRA5 | P31644 | 1/20 | 0.48 |
| ▸ | GABRA3 | P34903 | 1/20 | 0.48 |
| ▸ | HTR2B | P41595 | 1/20 | 0.48 |
| ▸ | GABRA2 | P47869 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL66227 | 0.84 | GABRA1 (0.57) | GABRA1GABRG2GABRB3GABRB2LMNA | |
| SCHEMBL8340259 | 0.84 | GABRA1 (0.38) | GABRA1GABRG2GABRB3GABRB2LMNA | |
| SCHEMBL9539486 | 0.82 | LMNA (0.50) | GABRA1GABRG2GABRB3GABRB2LMNA | |
| SCHEMBL29151002 | 0.81 | GABRA1 (0.55) | GABRA1GABRG2GABRB3GABRB2LMNA | |
| Benzene SCHEMBL7864298 | 0.81 | GABRA1 (0.55) | GABRA1GABRG2GABRB3GABRB2LMNA | |
| SCHEMBL28509290 | 0.81 | GABRA1 (0.55) | GABRA1GABRG2GABRB3GABRB2LMNA | |
| Hydrochloric Acid SCHEMBL27766942 | 0.81 | GABRA1 (0.55) | GABRA1GABRG2GABRB3GABRB2LMNA | |
| Hydrogen Sulfide SCHEMBL28223639 | 0.81 | GABRA1 (0.55) | GABRA1GABRG2GABRB3GABRB2LMNA | |
| Water SCHEMBL27976303 | 0.81 | GABRA1 (0.55) | GABRA1GABRG2GABRB3GABRB2LMNA | |
| SCHEMBL28270678 | 0.80 | LMNA (0.32) | GABRA1GABRG2GABRB3GABRB2LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109554122-B | Curing adhesive for polarizing film, optical film, and image display device | 日东电工株式会社 | 2022-03-01 | — | — | CN | disclosed |
| CN-109536046-B | Curing adhesive for polarizing film, optical film, and image display device | 日东电工株式会社 | 2021-06-11 | — | — | CN | disclosed |
| CN-106661386-B | Method for manufacturing laminated optical film | 日东电工株式会社 | 2020-10-23 | — | — | CN | disclosed |
| CN-105849598-B | Laminated polarizing film, method for producing same, laminated optical film, and image display device | 日东电工株式会社 | 2020-02-07 | — | — | CN | disclosed |
| US-9884043-B2 | RORgammaT inhibitors | MERCK SHARP & DOHME CORP. (US) | 2018-02-06 | — | — | US | disclosed |
| US-20170340610-A1 | RORgammaT INHIBITORS | MERCK SHARP & DOHME LLC | 2017-11-30 | — | — | US | disclosed |
| US-20160213891-A1 | Medical Dilation Element | ZAMORE, ALAN | 2016-07-28 | — | — | US | disclosed |
| US-9333278-B2 | Medical dilation element | Medtech Capital Ventures LLC (US) | 2016-05-10 | — | — | US | disclosed |
| US-20120070599-A1 | Reduced profile medical balloon element | ZAMORE, ALAN | 2012-03-22 | — | — | US | disclosed |
| US-20100249906-A1 | REDUCED PROFILE MEDICAL BALLOON ELEMENT | ZAMORE ALAN M | 2010-09-30 | — | — | US | disclosed |
| US-7749585-B2 | Reduced profile medical balloon element | ZAMORE, ALAN | 2010-07-06 | — | — | US | disclosed |
| US-20040093008-A1 | Reduced profile medical balloon element | ZAMORE, ALAN | 2004-05-13 | — | — | US | disclosed |
| US-4476255-A | Photoreactive plastic composition and articles degradable by ultraviolet radiation and a process for their manufacture | OWENS-ILLINOIS, INC. (US) | 1984-10-09 | — | — | US | disclosed |
| EP-0050261-A1 | Moulding masses stabilized against thermolysis with a low monomer content | BAYER AG (DE) | 1982-04-28 | — | — | EP | disclosed |
| US-4264658-A | Three-component polymeric coating for glass substrate | OWENS-ILLINOIS, INC. (US) | 1981-04-28 | — | — | US | disclosed |
| US-4094756-A | Photochemical modification of polymers | OWENS-ILLINOIS, INC. (US) | 1978-06-13 | — | — | US | disclosed |
| US-4086373-A | Protective polymeric coating for glass substrate | OWENS-ILLINOIS, INC. (US) | 1978-04-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170340610-A1 | RORgammaT INHIBITORS | RORB, RORC, RORA | GABRA1 210/4885GABRG2 138/4885GABRB3 206/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.